Richard F Ambinder

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Antiretroviral Therapy

Hodgkin Lymphoma

Prognostic Factors

Circulating Tumor

Top Venues

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Skoloda, Matthew J Newman, Haval Norman, Jamie E Ziggas, Richard F Ambinder
Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients. JCO oncology practice (2024)
Daniel Skoloda, Matthew J Newman, Haval Norman, Jamie E Ziggas, Richard F Ambinder
Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients. JCO oncology practice 20 (5) (2024)
Amy DeZern, Marianna L Zahurak, Heather J Symons, Kenneth R Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip Hollingsworth Imus, Nina D Wagner-Johnston, Richard F Ambinder, Mark J Levis, Leo Luznik, Javier Bolaños-Meade, Ephraim J Fuchs, Richard J Jones, Robert A Brodsky
Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood (2023)
Amy DeZern, Marianna L Zahurak, Heather J Symons, Kenneth R Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip Hollingsworth Imus, Nina D Wagner-Johnston, Richard F Ambinder, Mark J Levis, Leo Luznik, Javier Bolaños-Meade, Ephraim J Fuchs, Richard J Jones, Robert A Brodsky
Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood (2023)
Amy DeZern, Marianna L Zahurak, Heather J Symons, Kenneth R Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip Hollingsworth Imus, Nina D Wagner-Johnston, Richard F Ambinder, Mark J Levis, Leo Luznik, Javier Bolaños-Meade, Ephraim J Fuchs, Richard J Jones, Robert A Brodsky
Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood (2023)
Missak Haigentz, Jeannette Y Lee, Elizabeth Yu Chiao, David M Aboulafia, Lee Ratner, Richard F Ambinder, Robert A Baiocchi, Ronald T Mitsuyasu, William Wachsman, Joseph A Sparano, Michelle A Rudek
Phase I trial of the multi-kinase inhibitor cabozantinib, a CYP3A4 substrate, plus CYP3A4 interacting antiretroviral therapy in people living HIV and cancer (AMC087). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Rena R Xian, Richard F Ambinder
Cell-Free Circulating Tumor DNA and Epstein-Barr Virus DNA for Early Diagnosis of Epstein-Barr Virus-Associated Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Amy DeZern, Marianna L Zahurak, Heather J Symons, Kenneth R Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip Hollingsworth Imus, Nina D Wagner-Johnston, Richard F Ambinder, Mark J Levis, Leo Luznik, Javier Bolaños-Meade, Ephraim J Fuchs, Richard J Jones, Robert A Brodsky
Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood (2023)
Hema Dave, Madeline Terpilowski, Mimi Mai, Keri Toner, Melanie L Grant, Maja Stanojevic, Christopher Andrew Lazarski, Abeer Shibli, Stephanie Ann Bien, Philp Maglo, Fahmida Hoq, Reuven J Schore, Martha J Glenn, Boyu Hu, Patrick J Hanley, Richard F Ambinder, Catherine M Bollard
Tumor associated antigen specific T cells with nivolumab are safe and persist in vivo in rel/ref Hodgkin Lymphoma. Blood advances (2021)
Runxia Liu, Yang-Hui Jimmy Yeh, Ales Varabyou, Jack A Collora, Scott Sherrill-Mix, C Conover Talbot, Sameet Mehta, Kristen Albrecht, Haiping Hao, Hao Zhang, Ross A Pollack, Subul A Beg, Rachela M Calvi, Jianfei Hu, Christine M Durand, Richard F Ambinder, Rebecca Hoh, Steven G Deeks, Jennifer Chiarella, Serena Spudich, Daniel C Douek, Frederic D Bushman, Mihaela Pertea, Ya-Chi Ho
Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target. Science translational medicine 12 (543) (2021)
Michael D Keller, Sam Darko, Haili Lang, Amy Ransier, Christopher A Lazarski, Yunfei Wang, Patrick J Hanley, Blachy J Davila, Jennifer R Heimall, Richard F Ambinder, A John Barrett, Cliona M Rooney, Helen E Heslop, Daniel C Douek, Catherine M Bollard
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy. British journal of haematology 187 (2) (2019)